Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 183

1.

MicroRNA expression profile of mouse lung infected with 2009 pandemic H1N1 influenza virus.

Wu Z, Hao R, Li P, Zhang X, Liu N, Qiu S, Wang L, Wang Y, Xue W, Liu K, Yang G, Cui J, Zhang C, Song H.

PLoS One. 2013 Sep 16;8(9):e74190. doi: 10.1371/journal.pone.0074190.

2.

MicroRNA expression and virulence in pandemic influenza virus-infected mice.

Li Y, Chan EY, Li J, Ni C, Peng X, Rosenzweig E, Tumpey TM, Katze MG.

J Virol. 2010 Mar;84(6):3023-32. doi: 10.1128/JVI.02203-09.

3.

MicroRNA expression profiles and networks in mouse lung infected with H1N1 influenza virus.

Bao Y, Gao Y, Jin Y, Cong W, Pan X, Cui X.

Mol Genet Genomics. 2015 Oct;290(5):1885-97. doi: 10.1007/s00438-015-1047-1.

PMID:
25893419
4.

Integrative analysis of differentially expressed microRNAs of pulmonary alveolar macrophages from piglets during H1N1 swine influenza A virus infection.

Jiang P, Zhou N, Chen X, Zhao X, Li D, Wang F, Bi L, Zhang D.

Sci Rep. 2015 Feb 2;5:8167. doi: 10.1038/srep08167.

5.

Pulmonary immune responses to 2009 pandemic influenza A (H1N1) virus in mice.

Lv J, Wang D, Hua YH, Pei SJ, Wang J, Hu WW, Wang XL, Jia N, Jiang QS.

BMC Infect Dis. 2014 Apr 12;14:197. doi: 10.1186/1471-2334-14-197.

6.

Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection.

Bahgat MM, Błazejewska P, Schughart K.

Virol J. 2011 Jan 20;8:27. doi: 10.1186/1743-422X-8-27.

7.

Pathogenesis of pandemic influenza A (H1N1) and triple-reassortant swine influenza A (H1) viruses in mice.

Belser JA, Wadford DA, Pappas C, Gustin KM, Maines TR, Pearce MB, Zeng H, Swayne DE, Pantin-Jackwood M, Katz JM, Tumpey TM.

J Virol. 2010 May;84(9):4194-203. doi: 10.1128/JVI.02742-09.

8.

Differential microRNA expression and virulence of avian, 1918 reassortant, and reconstructed 1918 influenza A viruses.

Li Y, Li J, Belisle S, Baskin CR, Tumpey TM, Katze MG.

Virology. 2011 Dec 20;421(2):105-13. doi: 10.1016/j.virol.2011.09.011.

9.

Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1).

Song H, Wang Q, Guo Y, Liu S, Song R, Gao X, Dai L, Li B, Zhang D, Cheng J.

BMC Infect Dis. 2013 Jun 3;13:257. doi: 10.1186/1471-2334-13-257.

10.

MicroRNA expression in mice infected with seasonal H1N1, swine H1N1 or highly pathogenic H5N1.

Vela EM, Kasoji MD, Wendling MQ, Price JA, Knostman KA, Bresler HS, Long JP.

J Med Microbiol. 2014 Sep;63(Pt 9):1131-42. doi: 10.1099/jmm.0.067959-0.

PMID:
24913561
11.

Host microRNA molecular signatures associated with human H1N1 and H3N2 influenza A viruses reveal an unanticipated antiviral activity for miR-146a.

Terrier O, Textoris J, Carron C, Marcel V, Bourdon JC, Rosa-Calatrava M.

J Gen Virol. 2013 May;94(Pt 5):985-95. doi: 10.1099/vir.0.049528-0.

PMID:
23343627
12.

Transcription analysis on response of swine lung to H1N1 swine influenza virus.

Li Y, Zhou H, Wen Z, Wu S, Huang C, Jia G, Chen H, Jin M.

BMC Genomics. 2011 Aug 8;12:398. doi: 10.1186/1471-2164-12-398.

13.

Differential microRNA expression following infection with a mouse-adapted, highly virulent avian H5N2 virus.

Choi EJ, Kim HB, Baek YH, Kim EH, Pascua PN, Park SJ, Kwon HI, Lim GJ, Kim S, Kim YI, Choi YK.

BMC Microbiol. 2014 Sep 30;14:252. doi: 10.1186/s12866-014-0252-0.

14.

Influenza A(H1N1)pdm09 virus suppresses RIG-I initiated innate antiviral responses in the human lung.

Wu W, Zhang W, Booth JL, Metcalf JP.

PLoS One. 2012;7(11):e49856. doi: 10.1371/journal.pone.0049856.

15.

Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection.

Loveday EK, Svinti V, Diederich S, Pasick J, Jean F.

J Virol. 2012 Jun;86(11):6109-22. doi: 10.1128/JVI.06892-11.

16.

Integrated network analysis reveals a novel role for the cell cycle in 2009 pandemic influenza virus-induced inflammation in macaque lungs.

Shoemaker JE, Fukuyama S, Eisfeld AJ, Muramoto Y, Watanabe S, Watanabe T, Matsuoka Y, Kitano H, Kawaoka Y.

BMC Syst Biol. 2012 Aug 31;6:117. doi: 10.1186/1752-0509-6-117.

17.

Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets.

Kang YM, Song BM, Lee JS, Kim HS, Seo SH.

Arch Virol. 2011 May;156(5):759-67. doi: 10.1007/s00705-010-0914-7.

PMID:
21234768
18.

Reassortant H1N1 influenza virus vaccines protect pigs against pandemic H1N1 influenza virus and H1N2 swine influenza virus challenge.

Yang H, Chen Y, Shi J, Guo J, Xin X, Zhang J, Wang D, Shu Y, Qiao C, Chen H.

Vet Microbiol. 2011 Sep 28;152(3-4):229-34. doi: 10.1016/j.vetmic.2011.04.032.

PMID:
21596495
19.

Laninamivir octanoate and artificial surfactant combination therapy significantly increases survival of mice infected with lethal influenza H1N1 Virus.

Fukushi M, Yamashita M, Miyoshi-Akiyama T, Kubo S, Yamamoto K, Kudo K.

PLoS One. 2012;7(8):e42419. doi: 10.1371/journal.pone.0042419.

20.

Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus.

Busquets N, Segalés J, Córdoba L, Mussá T, Crisci E, Martín-Valls GE, Simon-Grifé M, Pérez-Simó M, Pérez-Maíllo M, Núñez JI, Abad FX, Fraile L, Pina S, Majó N, Bensaid A, Domingo M, Montoya M.

Vet Res. 2010 Sep-Oct;41(5):74. doi: 10.1051/vetres/2010046.

Items per page

Supplemental Content

Support Center